Echo Street Capital Management’s NovoCure NVCR Stock Holding History

Echo Street Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,880	Closed	-$200K	–	655
2022 Q2	$200K	Buy	+2,880	New	+$217K	﹤0.01%	503
2021 Q4	–	Sell	-1,975	Closed	-$229K	–	716
2021 Q3	$229K	Buy	1,975 +421	+27%	+$63.7K	﹤0.01%	554
2021 Q2	$345K	Buy	+1,554	New	+$302K	﹤0.01%	464
2021 Q1	–	Sell	-6,025	Closed	-$1.04M	–	572
2020 Q4	$1.04M	Buy	+6,025	New	+$824K	0.01%	161

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Echo Street Capital Management's NVCR Position: Q3 2022 in Review

Echo Street Capital Management sold out of NovoCure (NVCR) in Q3 2022, closing a stake of 2,880 shares — an estimated $200K sold.

Echo Street Capital Management first reported a position in NVCR in Q4 2020 and held it in 4 quarters. The position peaked at $1.04M in Q4 2020. 303 funds tracked by Wall St. Rank hold NVCR as of Q3 2022.

Echo Street Capital Management reported no remaining NovoCure position as of Q3 2022 after selling out during the quarter.
Echo Street Capital Management sold 2,880 NovoCure shares in Q3 2022, an estimated $200K.
Echo Street Capital Management first reported a position in NovoCure in Q4 2020 and held it in 4 quarters.
Echo Street Capital Management's NovoCure position peaked at $1.04M in Q4 2020.
303 funds tracked by Wall St. Rank held NovoCure as of Q3 2022.

Based on Echo Street Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.